Analytica Limited Announcements http://www.AnalyticaMedical.com Australian Stock Exchange and Other Announcements by Analytica Limited. Saturday Sunday 1440 Appendix 4C http://www.AnalyticaMedical.com/downloads/2010/20100730-ASX-ALT-Appendix4C.pdf Analytica presents its Appendix 4C for the quarter ended June 2010. 30 Jul 2010 Appendix 4C http://www.AnalyticaMedical.com/downloads/2010/20100427-ASX-ALT-Appendix4C.pdf Analytica presents its Appendix 4C for the quarter ended March 2010. 27 Apr 2010 Licensing and Distribution Agreement signed with Medical Australia http://www.AnalyticaMedical.com/downloads/2010/20100413-ASX-ALT-MLA-Agreement.pdf Medical products manufacturer and distributor Medical Australia Limited (ASX: MLA), today announced that it has signed a licensing and distribution agreement with Analytica Limited (ASX: ALT), a leading Australian medical technology company focussing on the development and commercialisation of a range of medical devices and pharmaceutical implants. 13 Apr 2010 Appendix 3B http://www.AnalyticaMedical.com/downloads/2010/20100413-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement 13 Apr 2010 Section 708A(5)(e) Notice http://www.AnalyticaMedical.com/downloads/2010/20100413-ASX-ALT-CleansingNotice.pdf 13 Apr 2010 Change of Company Secretary http://www.AnalyticaMedical.com/downloads/2010/20100401-ASX-ALT-CompanySecretary.pdf The Analytica Board advises that Ben Graham has resigned as Company Secretary and Jennie Yuen has been appointed as Company Secretary of Analytica Limited, effective immediately 1 Apr 2010 Appendix 3B http://www.AnalyticaMedical.com/downloads/2010/20100312-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement 12 Mar 2010 AutoStart Burette Recieves FDA 510(k) Clearance http://www.AnalyticaMedical.com/downloads/2010/20100309-ASX-ALT-FDA510k.pdf Analytica Ltd is pleased to announce receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the AutoStart Burette in the United States. This is a significant milestone in the commercialisation of the AutoStart Burette, opening up one of the world's most significant medical device market. 9 Mar 2010 Appendix 3B http://www.AnalyticaMedical.com/downloads/2010/20100302-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement 2 Mar 2010 Form 603 http://www.AnalyticaMedical.com/downloads/2010/20100302-ASX-ALT-Form603.pdf Notice of initial substantial holder 2 Mar 2010 Appendix 4D - Half Yearly Report http://www.AnalyticaMedical.com/downloads/2010/20100226-ASX-ALT-Appendix4D.pdf For the 6 months ended December 2009 (current period) and the previous corresponding period 6 months ended 31 December 2008 26 Feb 2010 Market Update http://www.AnalyticaMedical.com/downloads/2010/20100205-ASX-ALT-MarketUpdate.pdf Analytica Limited wishes to advise that its National Health and Medical Research Council (NHMRC) grant application has been unsuccessful. Analytica, in conjunction with Professor Paul Haber of the University of Sydney, applied for a NHMRC grant to partly fund the early stages of its Naltrexone implant program. Analytica is aiming to produce a TGA-approved Naltrexone implant for the treatment of drug and alcohol addiction. Currently, there is no generally available, TGA-approved implant to treat such addictions. 5 Feb 2010 Appendix 4C http://www.AnalyticaMedical.com/downloads/2010/20100129-ASX-ALT-Appendix4C.pdf Analytica presents its Appendix 4C for the quarter ended 31 December 2009. 29 Jan 2010 Appendix 3B http://www.AnalyticaMedical.com/downloads/2010/20100122-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement. 22 Jan 2010 Market Update http://www.AnalyticaMedical.com/downloads/2009/20091224-ASX-ALT-Update.pdf Further to the announcement to the market on 12 October 2009, Analytica Limited wishes to advise that its Pre-Market Notification (510(k)) application for the AutoStart® Burette is still under consideration by the FDA Office for Device Evaluation. Analytica understands that that the FDA workload is currently unusually high due to the agency's recent change in premises. Analytica is not aware of any impediment to the AutoStart® Burette receiving the required approvals from the FDA to be marketed in the United States and will advise the market of further developments as they occur. The Company also remains on target to complete a formal distribution and licensing agreement with Medical Australia Limited (MLA) in the New Year. The Agreement will provide MLA with an exclusive right for the distribution of the AutoStart® Burette in Australia, New Zealand and the UK, with a springboard into Asia, Europe and the middle east. 24 Dec 2009 Correction - Location of Share Register http://www.AnalyticaMedical.com/downloads/2009/20091223-ASX-ALT-ShareRegisterCorx.pdf The announcement made by the Company on 21 December concerning the location of its share registry, Link Market Services, contained a typographical error. Link Market Services has relocated to Level 15, 324 Queen Street, Brisbane 4000. The previous announcement incorrectly stated Level 19. All telephone and fax numbers remain unchanged. 23 Dec 2009 Location of Share Register http://www.AnalyticaMedical.com/downloads/2009/20091221-ASX-ALT-ShareRegister.pdf Analytica Limited (ASX: ALT) advises in accordance with Listing Rule 3.15.1, that the Company's share registry, Link Market Services, has relocated to Level 19, 324 Queen Street, Brisbane 4000. All telephone and fax numbers remain unchanged. 21 Dec 2009 Appendix 3B http://www.AnalyticaMedical.com/downloads/2009/20091204-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement. 4 Dec 2009 Appendix 3Y http://www.AnalyticaMedical.com/downloads/2009/20091204-ASX-ALT-Appendix3Y.pdf Change of Director's Interest Notice. 4 Dec 2009 AGM 2009 - Results http://www.AnalyticaMedical.com/downloads/2009/20091127-ASX-ALT-ResultsAGM2009.pdf 27 Nov 2009 AGM 2009 - Operations Report http://www.AnalyticaMedical.com/downloads/2009/20091127-ASX-ALT-OperationsReport-AGM2009.pdf 27 Nov 2009 AGM 2009 - Chairman's Address http://www.AnalyticaMedical.com/downloads/2009/20091127-ASX-ALT-ChairmansAddress-AGM2009.pdf 27 Nov 2009 Medical Australia and Analytica Sign Licensing and Distribution Heads of Agreement. http://www.AnalyticaMedical.com/downloads/2009/20091126-ASX-ALT-MLA-HeadsOfAgreement.pdf

• Multifaceted agreement including the manufacture, regulatory sponsorship and marketing of the Analytica AutoStart® Burette device and AutoFlush feature.

• Exclusive distribution opportunity encompassing Australia, New Zealand and UK, with springboard into Asia, Middle East and EU.

• Long-term strategic alliance to form product development, commercialisation and distribution partnership.

 26 Nov 2009 Trading Halt http://www.AnalyticaMedical.com/downloads/2009/20091125-ASX-ALT-TradingHalt.pdf ASX Market Release 25 Nov 2009 Trading Halt Request http://www.AnalyticaMedical.com/downloads/2009/20091125-ASX-ALT-TradingHaltRequest.pdf Pursuant to listing Rule 17.1, Analytica Limited requests an immediate trading halt of the company's securities ("ASX: ALT") pending the release of a material announcement concerning the distribution of the company's AutoStart® Burette product. The company expects to make this announcement before the opening of trade on Friday morning (Nov 27). 25 Nov 2009 ASX Price Query Response http://www.AnalyticaMedical.com/downloads/2009/20091105-ASX-ALT-ASXPriceQueryResponse.pdf Response to query by the ASX regarding recent price changes. 05 Nov 2009 First Commercial Sale of AutoStart® Burette http://www.AnalyticaMedical.com/downloads/2009/20091030-ASX-ALT-1stASBSale.pdf Analytica is pleased to announce that it has received its first commercial order for the AutoStart® Burette following extensive trials with a State Government Hospital. This order marks a major milestone in the product lifecycle and moves Analytica's focus from development to production. 30 Oct 2009 Company Update - FDA 510(k) Application Acceptance http://www.AnalyticaMedical.com/downloads/2009/20091012-ASX-ALT-FDA510kReceipt.pdf Analytica is pleased to announce that the US Food and Drug Administration has received and accepted a Premarket Notification (510(k)) application for the AutoStart® Burette. The 510(k) is a submission made to the FDA demonstrating that the AutoStart Burette is at least as safe and effective as existing legally marketed burette devices. Before supplying the AutoStart Burette to the US, Analytica must receive a letter from FDA which finds the device to be substantially equivalent and clears the device to be marketed. 510(k) clearances typically take several months. 12 Oct 2009 Appendix 4C - Quarterly Cash Flow http://www.AnalyticaMedical.com/downloads/2009/20091001-ASX-ALT-Appendix4C.pdf Analytica presents its Appendix 4C for the quarter ended 30 September 2009. 01 Oct 2009